Pharmaceutical agents for treatment of leishmaniasis: a patent landscape.

Yasmim Maria Barbosa Gomes de Carvalho Saravanan ShanmugamMayrton Santos BatistaMairim Russo SerafiniAdriano Antunes De Souza AraújoLucindo José Quintans-Junior

Published in: Expert opinion on therapeutic patents (2020)

Universities or public research institutes produced most of the patents related to pharmaceutical agents for treatment of leishmaniasis in this review, and the majority of the inventions disclosed did not conduct clinical trials. In other words, there is still a lot of investment to be done for the identification of new drugs.

Keyphrases

clinical trial
randomized controlled trial
emergency department
combination therapy
single cell
study protocol
replacement therapy
phase ii